Shenzhen Intellifusion Technologies Confirms Shenzhen Looka Doctor Technology as Its Wholly Owned Subsidiary

Deep News
2025/12/24

Shenzhen Intellifusion Technologies Co., Ltd. (Intellifusion) clarified in response to investor inquiries that Shenzhen Looka Doctor Technology Co., Ltd. is its wholly owned subsidiary. The subsidiary launched its first product, the Looka Doctor AI Learning Camera, under its self-owned brand at the end of 2024. The device integrates the self-developed "Intellifusion Tian Shu" multimodal large model and combines multimodal recognition technology to achieve a "capture-identify-educate" loop, offering scenario-based knowledge interaction for children.

Following its release, the AI Learning Camera won multiple awards, including the 2025 Red Dot Design Award, "Cultural Expo Gift," and "Shenzhen Souvenir." In late October 2025, Looka Doctor introduced its second product, the AI Pet Dog, leveraging the IFMind large model and an independently developed embedded voiceprint model. This product simulates real pet care scenarios through multimodal visual recognition, aiming to cultivate responsibility in children. It is currently available for sale on multiple online platforms.

Moving forward, Intellifusion plans to implement a multi-dimensional growth strategy for its consumer-facing products: advancing the Looka Doctor brand IP, establishing an omnichannel marketing system, and enhancing user co-creation and brand promotion. The company will also utilize core technologies like large models to empower consumer electronics such as AI glasses, introduce new smart device categories, and explore a "hardware + subscription content/service" model while deepening technological iteration and cost optimization to build competitive barriers. Additionally, Intellifusion aims to expand into overseas markets by developing multilingual product versions and services.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10